Mostafa Ronaghi
CIK: 0001441876
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SMMT
Summit Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Ronaghi Mostafa
Ronaghi Mostafa (SEC CIK 0001441876) files insider reports with the SEC as Director of Summit Therapeutics Inc. (SMMT).
Signal8 holds 2 ownership filings by Ronaghi Mostafa, all Form 4s, filed between Jan 6, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ronaghi Mostafa's filings is in MIAMI, FL.
Recent filings by Ronaghi Mostafa
Other insiders filing for Summit Therapeutics Inc. (SMMT)
- Anand Bhaskar, Chief Accounting Officer
- Zanganeh Mahkam, Co-Chief Executive Officer
- DUGGAN ROBERT W, Co-Chief Executive Officer
- Soni Manmeet Singh, COO and CFO
- Booth Robert F., Director
- Xia Yu, Director